[
  {
    "date": "2022-12-30",
    "symbol": "OCUP",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentannualreport": "true",
    "documentperiodenddate": "December 31, 2022",
    "currentfiscalyearenddate": "12-31",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-34079",
    "entityregistrantname": "Ocuphire Pharma, Inc.",
    "entitycentralindexkey": 1228627,
    "entityincorporationstatecountrycode": "Delaware",
    "entitytaxidentificationnumber": "11-3516358",
    "entityaddressaddressline1": "37000 Grand River Avenue, Suite 120",
    "entityaddresscityortown": "Farmington Hills",
    "entityaddressstateorprovince": "MI",
    "entityaddresspostalzipcode": 48335,
    "cityareacode": 248,
    "localphonenumber": "681-9815",
    "security12btitle": "Common Stock, $0.0001 par value per share",
    "tradingsymbol": "OCUP",
    "securityexchangename": "The Nasdaq Stock Market LLC",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "icfrauditorattestationflag": "false",
    "entityshellcompany": "false",
    "auditorname": "Ernst & Young LLP",
    "auditorlocation": "Detroit, Michigan",
    "auditorfirmid": 42,
    "cashandcashequivalentsatcarryingvalue": 42634000,
    "accountsreceivablenetcurrent": 1298000,
    "contractassetcurrent": 3552000,
    "prepaidexpenseandotherassetscurrent": 1453000,
    "shortterminvestments": 49000,
    "assetscurrent": 48986000,
    "propertyplantandequipmentnet": 6000,
    "assets": 48992000,
    "accountspayablecurrent": 1069000,
    "accruedliabilitiescurrent": 1684000,
    "liabilitiescurrent": 2753000,
    "liabilities": 2753000,
    "commonstockvalue": 2000,
    "additionalpaidincapital": 117717000,
    "retainedearningsaccumulateddeficit": -71480000,
    "stockholdersequity": -71480000,
    "liabilitiesandstockholdersequity": 48992000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 75000000,
    "commonstocksharesissued": 20861315,
    "commonstocksharesoutstanding": 20861315,
    "revenuefromcontractwithcustomerexcludingassessedtax": 331000,
    "generalandadministrativeexpense": 7269000,
    "researchanddevelopmentexpenseexcludingacquiredinprocesscost": 14355000,
    "operatingexpenses": 21624000,
    "operatingincomeloss": 18226000,
    "interestexpense": 9000,
    "gainlossonderivativeinstrumentsnetpretax": 33800000,
    "othernonoperatingincomeexpense": -14000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": 18203000,
    "incometaxexpensebenefit": 315000,
    "netincomeloss": 17888000,
    "comprehensiveincomenetoftax": 17888000,
    "earningspersharebasic": 0.9,
    "earningspersharediluted": 0.87,
    "weightedaveragenumberofsharesoutstandingbasic": 19931080,
    "weightedaveragenumberofdilutedsharesoutstanding": 20597212,
    "sharesoutstanding": 20861315,
    "stockissuedduringperiodvalueatthemarketprogram": 4428000,
    "stockissuedduringperiodsharesatthemarketprogram": 1848980,
    "adjustmentstoadditionalpaidincapitalissuancecostsrelatedtocommonstockatmandregistereddirectfinancing": 133000,
    "stockissuedduringperiodsharesexerciseofwarrants": 60832,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 1807000,
    "stockissuedduringperiodsharessharebasedcompensation": 81366,
    "stockissuedduringperiodvaluestockoptionsexercised": 27000,
    "stockissuedduringperiodsharesstockoptionsexercised": 24309,
    "sharebasedcompensation": 1807000,
    "depreciation": 4000,
    "unrealizedgainlossoninvestments": -170000,
    "increasedecreaseinaccountsreceivable": 1298000,
    "increasedecreaseincontractassetcurrent": 3552000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 139000,
    "increasedecreaseinaccountspayable": -515000,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": -51000,
    "netcashprovidedbyusedinoperatingactivities": 14314000,
    "proceedsfromissuanceofcommonstock": 4400000,
    "paymentsofstockissuancecosts": 133000,
    "repaymentsofshorttermdebt": 538000,
    "proceedsfromstockoptionsexercised": 27000,
    "netcashprovidedbyusedinfinancingactivities": 3786000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": 18100000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 42634000,
    "interestpaidnet": 9000,
    "noncashorpartnoncashacquisitionotherliabilitiesassumed1": 2000,
    "numberofsmallmoleculeproductcandidates": 2,
    "numberofoperatingsegments": 1,
    "cashuninsuredamount": 42100000,
    "assetsfairvaluedisclosure": 49000,
    "investmentsfairvaluedisclosure": 49000,
    "propertyplantandequipmentusefullife": "five-year",
    "contingentvaluerightspaymentperiod": 15,
    "contingentvaluerightsipterm": 10,
    "classofwarrantorrightoutstanding": 1538461,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 0.0001,
    "weightedaverageremainingcontractualtermswarrants": 1,
    "numberofdirectors": 1,
    "warrantsandrightsoutstandingterm": "five years",
    "derivativeassetmeasurementinput": 0.866,
    "fairvalueassumptionsexpectedlife": 4.8,
    "operatingleasesmonthlybaserent": 13000,
    "operatingleasecost": 39000,
    "lesseeoperatingleaseliabilitypaymentsduenextrollingtwelvemonths": 36000,
    "stockissuedduringperiodsharesnewissues": 1848980,
    "prepaidexpensecurrent": 1373000,
    "otherassetscurrent": 80000,
    "propertyplantandequipmentgross": 25000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 19000,
    "taxespayablecurrent": 315000,
    "employeerelatedliabilitiescurrent": 782000,
    "accruedprofessionalfeescurrent": 208000,
    "accruedresearchanddevelopmentservicesandsuppliescurrent": 212000,
    "otheraccruedliabilitiescurrent": 167000,
    "debtinstrumentnumberofinstallments": 6,
    "shorttermdebtpercentagebearingfixedinterestrate": 0.055,
    "amountinvestedinpremergerfinancing": 300000,
    "numberofconvertedinitialsharesreceivedbydirectors": 17729,
    "numberofconvertedadditionalsharesreceivedbydirectors": 9444,
    "numberofdirectorssignedwaiveragreements": 6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 893305,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "36 months",
    "relatedpartytransactionexpensesfromtransactionswithrelatedparty": 105000,
    "duetorelatedpartiescurrentandnoncurrent": 25000,
    "allocatedsharebasedcompensationexpense": 1700000,
    "maximumperiodofsharesreservedunderplan": "ten years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardpercentageofoutstandingstockmaximum": 0.05,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 48,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 2936044,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiod": 29788,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 2936044,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableservicetimeconditionnumber": 1723792,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 2.87,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 2.64,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 1.09,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice": 6.21,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingservicetimeconditionweightedaverageexerciseprice": 2.87,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 2.56,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": 7.82,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingservicetimeconditionweightedaverageremainingcontractualterm": 7.82,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": 7.07,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 3314000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingservicetimeconditionaggregateintrinsicvalue": 3314000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 1680000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedintrinsicvalue": 3.53,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedweightedaveragegrantdatefairvalue": 3.29,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.9740000000000001,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 5.8,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.023,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 488621,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedoptionsforfeitednumberofshares": 29788,
    "commonstockcapitalsharesavailableforfutureissuance": 894920,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 2600000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 1.2,
    "stockissuedduringperiodsharesissuedforservices": 74396,
    "numberofboardmembersgrantedstockforservices": 4,
    "employeebenefitsandsharebasedcompensation": 154000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 82,
    "futuremilestonemethodrevenuenotrecognized": 20000000,
    "minimumpercentageofbeneficialownership": 0.0499,
    "maximumpercentageofbeneficialownershiplimitation": 0.0999,
    "nonrefundablecashpaymentreceived": 35000000,
    "maximumamountofpaymentsreceivablefordevelopmentregulatoryandcommercialmilestones": 84500000,
    "maximumpercentageoftieredroyaltiesreceivable": 0.2,
    "numberofperformanceobligations": 2,
    "contractassetreclassificationtoaccountsreceivablerelatedtocostsbilledunderlicenseagreement": 1298000,
    "periodofrestrictionfromsellingstock": "one year",
    "numberoftimespaymentsforsalesmilestone": 1,
    "percentageofmilestonepaymentseligibletoreceiveonsublicenseagreement": 0.32,
    "minimumnumberofcountriesdevelopmentactivitiestobeconducted": 1,
    "milestoneperiodtoadministerdrugclinicaltrialoflicensedproductonfirstpatient": 3,
    "milestoneperiodtoadministerdrugclinicaltrialoflicensedproductonfirstpatientforsecondindication": 5,
    "periodofopportunitytocurebreachofagreement": 120,
    "periodofpriorwrittennoticetobeservedforterminationofagreements": "120 days",
    "incrementalcommonsharesattributabletooptions": 589165,
    "incrementalcommonsharesattributabletowarrants": 76967,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 60713,
    "effectiveincometaxbenefitprovisionratereconciliationatfederalstatutoryincometaxratepercent": 0.21,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.214,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.049,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": 0.004,
    "effectiveincometaxratereconciliationnondeductibleexpenseresearchanddevelopment": 0.031000000000000003,
    "effectiveincometaxratereconciliationnondeductibleexpenseother": -0.001,
    "effectiveincometaxratecontinuingoperations": 0.017,
    "currentfederaltaxexpensebenefit": 279000,
    "currentstateandlocaltaxexpensebenefit": 36000,
    "currentincometaxexpensebenefit": 315000,
    "deferredtaxassetsoperatinglosscarryforwards": 10300000,
    "deferredtaxassetsgoodwillandintangibleassets": 547000,
    "deferredtaxassetsinprocessresearchanddevelopment": 2820000,
    "deferredtaxassetstaxdeferredexpenseother": 7000,
    "deferredtaxassetsother": 62000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 1152000,
    "deferredtaxassetsresearchanddevelopment": 731000,
    "deferredtaxassetsgross": 18406000,
    "deferredtaxassetsvaluationallowance": 17770000,
    "deferredtaxassetsnet": 636000,
    "deferredrevenue": 636000,
    "deferredincometaxliabilities": 636000,
    "operatinglosscarryforwards": 10900000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 700000,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 2200000,
    "federaloperatinglosscarryforwardstaxeffect": 4800000,
    "stateandlocaloperatinglosscarryforwardstaxeffect": 1400000,
    "utilizedfederalresearchcreditcarryforwards": 900000,
    "definedcontributionplanemployerdiscretionarycontributionamount": 76000
  },
  {
    "date": "2021-12-30",
    "symbol": "OCUP",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentannualreport": "true",
    "documentperiodenddate": "2021-12-31",
    "currentfiscalyearenddate": "--12-31",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-34079",
    "entityregistrantname": "Ocuphire Pharma, Inc.",
    "entitycentralindexkey": 1228627,
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "11-3516358",
    "entityaddressaddressline1": "37000 Grand River Avenue, Suite 120",
    "entityaddresscityortown": "Farmington Hills",
    "entityaddressstateorprovince": "MI",
    "entityaddresspostalzipcode": 48335,
    "cityareacode": 248,
    "localphonenumber": "681-9815",
    "security12btitle": "Common Stock, $0.0001 par value per share",
    "tradingsymbol": "OCUP",
    "securityexchangename": "NASDAQ",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "icfrauditorattestationflag": "false",
    "entityshellcompany": "false",
    "auditorname": "Ernst & Young LLP",
    "auditorlocation": "Detroit, Michigan",
    "auditorfirmid": 42,
    "cashequivalentsatcarryingvalue": 24534000,
    "prepaidexpenseandotherassetscurrent": 1314000,
    "shortterminvestments": 219000,
    "assetscurrent": 26067000,
    "propertyplantandequipmentnet": 10000,
    "assets": 26077000,
    "accountspayablecurrent": 1584000,
    "accruedliabilitiescurrent": 1733000,
    "shorttermborrowings": 538000,
    "liabilitiescurrent": 3855000,
    "liabilities": 3855000,
    "commitmentsandcontingencies": "null",
    "commonstockvalue": 2000,
    "additionalpaidincapital": 111588000,
    "retainedearningsaccumulateddeficit": -89368000,
    "stockholdersequity": 22222000,
    "liabilitiesandstockholdersequity": 26077000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 75000000,
    "commonstocksharesissued": 18845828,
    "commonstocksharesoutstanding": 18845828,
    "revenuefromcontractwithcustomerexcludingassessedtax": 589000,
    "generalandadministrativeexpense": 8121000,
    "researchanddevelopmentexpenseexcludingacquiredinprocesscost": 15173000,
    "operatingexpenses": 23294000,
    "operatingincomeloss": -22705000,
    "interestexpense": 2000,
    "gainlossonderivativeinstrumentsnetpretax": -33829000,
    "othernonoperatingincomeexpense": -157000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -56693000,
    "netincomeloss": -56693000,
    "comprehensiveincomenetoftax": -56693000,
    "earningspersharebasic": -3.82,
    "earningspersharediluted": -3.82,
    "weightedaveragenumberofsharesoutstandingbasic": 14852745,
    "weightedaveragenumberofdilutedsharesoutstanding": 14852745,
    "sharesoutstanding": 18845828,
    "stockissuedduringperiodsharesnewissues": 843751,
    "adjustmentstoadditionalpaidincapitalreclassificationofwarrantstoequity": 61793000,
    "stockissuedduringperiodvalueinconnectionwithregistereddirectoffering": 1000,
    "stockissuedduringperiodsharesinconnectionwithregistereddirectoffering": 3076923,
    "stockissuedduringperiodvalueatthemarketprogram": 13491000,
    "stockissuedduringperiodsharesatthemarketprogram": 2778890,
    "stockissuedduringperiodvalueinsettlementwithinvestors": 1614000,
    "stockissuedduringperiodsharesinsettlementwithinvestors": 350000,
    "adjustmentstoadditionalpaidincapitalissuancecostsrelatedtocommonstockatmandregistereddirectfinancing": 1517000,
    "stockissuedduringperiodsharesexerciseofwarrants": 1629634,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 1914000,
    "stockissuedduringperiodsharessharebasedcompensation": 54444,
    "stockissuedduringperiodvaluestockoptionsexercised": 87000,
    "stockissuedduringperiodsharesstockoptionsexercised": 73442,
    "sharebasedcompensation": 1914000,
    "depreciation": 4000,
    "sharesettlementwithinvestors": 1614000,
    "incomelossfrominvestmentsrelatedtolicenseagreement": 289000,
    "unrealizedgainlossoninvestments": -70000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 45000,
    "increasedecreaseinaccountspayable": 381000,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": -155000,
    "netcashprovidedbyusedinoperatingactivities": -19370000,
    "otherpaymentstoacquirebusinesses": 100000,
    "netcashprovidedbyusedininvestingactivities": -100000,
    "proceedsfromissuanceofcommonstock": 28491000,
    "paymentsofstockissuancecosts": 400000,
    "paymentofstockissuancecostsandfinancing": 1511000,
    "proceedsfromshorttermdebt": 646000,
    "repaymentsofshorttermdebt": 108000,
    "proceedsfromstockoptionsexercised": 87000,
    "netcashprovidedbyusedinfinancingactivities": 27605000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": 8135000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 24534000,
    "interestpaidnet": 2000,
    "noncashorpartnoncashreclassificationofwarrantstoequityamount": 61793000,
    "noncashorpartnoncashacquisitionotherliabilitiesassumed1": 6000,
    "numberofsmallmoleculeproductcandidates": 2,
    "stockholdersequitynotestocksplitconversionratio1": 1.0565,
    "numberofoperatingsegments": 1,
    "cashuninsuredamount": 24000000,
    "assetsfairvaluedisclosure": 219000,
    "investmentsfairvaluedisclosure": 219000,
    "receiptofinvestmentsrelatedtolicenseagreement": 289000,
    "fairvalueadjustmentofwarrants": 33829000,
    "propertyplantandequipmentusefullife": "P5Y",
    "contingentvaluerightspaymentperiod": "P15Y",
    "contingentvaluerightsipterm": "P10Y",
    "paymentsdueundercvragreement": 91000,
    "classofwarrantorrightoutstanding": 66538,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 38.4,
    "weightedaverageremainingcontractualtermswarrants": "P1Y10M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 82,
    "lesseeoperatingleasetermofcontract": "P7M",
    "operatingleasesmonthlybaserent": 3000,
    "operatingleasecost": 116000,
    "lesseeoperatingleaseliabilitypaymentsduenextrollingtwelvemonths": 36000,
    "prepaidexpensecurrent": 1243000,
    "otherassetscurrent": 71000,
    "propertyplantandequipmentgross": 20000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 15000,
    "accruedresearchanddevelopmentservicesandsuppliescurrent": 1081000,
    "employeerelatedliabilitiescurrent": 488000,
    "accruedprofessionalfeescurrent": 84000,
    "otheraccruedliabilitiescurrent": 80000,
    "debtinstrumentnumberofinstallments": 6,
    "debtinstrumentperiodicpayment": 108000,
    "shorttermdebtpercentagebearingfixedinterestrate": 0.055,
    "notespayablefairvaluedisclosure": 1300000,
    "adjustmentstoadditionalpaidincapitalconvertibledebtwithoutconversionfeature": 1000000,
    "debtinstrumentinterestratestatedpercentage": 0.08,
    "proceedsfromnewequityinvestments": 1000000,
    "debtinstrumentinterestrateinperiodofdefault": 0.12,
    "notespayablerelatedpartiescurrentandnoncurrent": 700000,
    "numberofboardmembers": 4,
    "numberofofficers": 2,
    "numberofofficersalsoaboard": 1,
    "numberofdirectors": 5,
    "amountinvestedinpremergerfinancing": 300000,
    "numberofconvertedinitialsharesreceivedbydirectors": 17729,
    "numberofconvertedadditionalsharesreceivedbydirectors": 53189,
    "numberofdirectorssignedwaiveragreements": 6,
    "allocatedsharebasedcompensationexpense": 1116000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P48M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 420300,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiod": 34220,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 1281263,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 2.97,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 5.72,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 1.88,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P8Y2M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": "P7Y7M17D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 345000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 2370000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedintrinsicvalue": 3.73,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedweightedaveragegrantdatefairvalue": 4.36,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.981,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y9M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.009,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 468301,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedoptionsforfeitednumberofshares": 34220,
    "commonstockcapitalsharesavailableforfutureissuance": 890542,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 2400000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P1Y1M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 40000,
    "stockissuedduringperiodsharesissuedforservices": 21414,
    "numberofboardmembersgrantedstockforservices": 2,
    "employeebenefitsandsharebasedcompensation": 108000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 41,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 182.4,
    "futuremilestonemethodrevenuenotrecognized": 11000000,
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": 1708334,
    "warrantsandrightsoutstandingterm": "P5Y",
    "fairvalueassumptionsexpectedlife": "P5Y",
    "minimumpercentageofbeneficialownership": 0.0499,
    "maximumpercentageofbeneficialownershiplimitation": 0.0999,
    "numberoftradingdays": "P10D",
    "percentageofresetprice": 1.2,
    "derivativeassetmeasurementinput": 0.004,
    "numberofinterestratederivativesheld": 1,
    "numberoftradingdaysincludingresetdate": "P45D",
    "periodofissuancedate": "P6M",
    "periodofafterissuancedate": "P1Y",
    "premoneyvaluationamount": 10000000,
    "noninterestexpensetransferagentandcustodianfees": 1600000,
    "legalfees": 200000,
    "milestonepaymentachievedforperformanceobligation": 100000,
    "maximumamountofpaymentsreceivablefordevelopmentregulatoryandcommercialmilestones": 84500000,
    "periodofrestrictionfromsellingstock": "P1Y",
    "numberoftimespaymentsforsalesmilestone": 1,
    "percentageofmilestonepaymentseligibletoreceiveonsublicenseagreement": 0.32,
    "minimumnumberofcountriesdevelopmentactivitiestobeconducted": 1,
    "milestoneperiodtoadministerdrugclinicaltrialoflicensedproductonfirstpatient": "P3Y",
    "milestoneperiodtoadministerdrugclinicaltrialoflicensedproductonfirstpatientforsecondindication": "P5Y",
    "periodofopportunitytocurebreachofagreement": "P120D",
    "periodofpriorwrittennoticetobeservedforterminationofagreements": "P120D",
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 7282999,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.119,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.048,
    "effectiveincometaxratereconciliationwarrantspercent": 0.153,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": -0.001,
    "effectiveincometaxratereconciliationnondeductibleexpenseresearchanddevelopment": -0.011,
    "effectiveincometaxratereconciliationnondeductibleexpenseother": -0.002,
    "deferredtaxassetsoperatinglosscarryforwards": 19244000,
    "deferredtaxassetsgoodwillandintangibleassets": 547000,
    "deferredtaxassetstaxdeferredexpenseother": 7000,
    "deferredtaxassetsother": 18000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 811000,
    "deferredtaxassetsresearchanddevelopment": 1035000,
    "deferredtaxassetsgross": 21662000,
    "deferredtaxassetsvaluationallowance": 21662000,
    "deferredtaxassetsoperatinglosscarryforwardsdomestic": 15700000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 1000000,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 3600000,
    "maximumperiodofsharesreservedunderplan": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardpercentageofoutstandingstockmaximum": 0.05
  },
  {
    "date": "2020-12-30",
    "symbol": "OCUP",
    "period": "FY",
    "entityregistrantname": "Ocuphire Pharma, Inc.",
    "entitycentralindexkey": 1228627,
    "currentfiscalyearenddate": "--12-31",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2020-12-31",
    "documentfiscalyearfocus": 2020,
    "documentfiscalperiodfocus": "FY",
    "entityaddressstateorprovince": "MI",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "cashequivalentsatcarryingvalue": 16399000,
    "prepaidexpenseandotherassetscurrent": 1269000,
    "assetscurrent": 17668000,
    "propertyplantandequipmentnet": 14000,
    "assets": 17682000,
    "accountspayablecurrent": 1214000,
    "accruedliabilitiescurrent": 1971000,
    "liabilitiescurrent": 3185000,
    "warrantsandrightsoutstanding": 27964000,
    "liabilities": 31149000,
    "commonstockvalue": 1000,
    "additionalpaidincapital": 19207000,
    "retainedearningsaccumulateddeficit": -32675000,
    "stockholdersequity": -32675000,
    "liabilitiesandstockholdersequity": 17682000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 75000000,
    "commonstocksharesissued": 10882495,
    "commonstocksharesoutstanding": 10882495,
    "generalandadministrativeexpense": 2818000,
    "researchanddevelopmentexpenseexcludingacquiredinprocesscost": 6648000,
    "researchanddevelopmentinprocess": 10502000,
    "operatingexpenses": 19968000,
    "operatingincomeloss": -19968000,
    "interestexpense": 6847000,
    "gainlossonderivativeinstrumentsnetpretax": 2100000,
    "gainslossesonextinguishmentofdebt": 3672000,
    "othernonoperatingincomeexpense": 9000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -24620000,
    "netincomeloss": -24620000,
    "comprehensiveincomenetoftax": -24620000,
    "earningspersharebasicanddiluted": -5.28,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 4661110,
    "sharesoutstanding": 10882495,
    "stockissuedduringperiodvaluenewissues": 2126000,
    "stockissuedduringperiodsharesnewissues": 843751,
    "adjustmentstoadditionalpaidincapitalconvertibledebtwithconversionfeature": 971000,
    "stockissuedduringperiodvalueconversionofconvertiblesecurities": 6953000,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": 977128,
    "stockissuedduringperiodvalueother": 1000,
    "stockissuedduringperiodsharesother": 4999988,
    "adjustmentstoadditionalpaidincapitalstockissuedissuancecosts": 1080000,
    "stockissuedduringperiodvalueacquisitions": 8115000,
    "stockissuedduringperiodsharesacquisitions": 1120800,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 1506000,
    "adjustmentstoadditionalpaidincapitalequitycomponentofconvertibledebt": -64000,
    "stockissuedduringperiodvaluestockoptionsexercised": 58000,
    "stockissuedduringperiodsharesstockoptionsexercised": 40672,
    "sharebasedcompensation": 1506000,
    "depreciation": 8000,
    "othernoncashexpense": 492000,
    "noncashinterestonconvertiblenotesrelatedparty": 51000,
    "amortizationofdebtdiscountpremium": 900000,
    "noncashdiscountamortizationonconvertiblenotesrelatedparty": 71000,
    "financingcostsreclassifiedfromoperatingactivitiestofinancingactivities": 4671000,
    "recapitalizationcosts": 689000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 906000,
    "increasedecreaseinaccountspayable": 792000,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": 1260000,
    "netcashprovidedbyusedinoperatingactivities": -6797000,
    "cashacquiredfromacquisition": 2014000,
    "otherpaymentstoacquirebusinesses": 1475000,
    "netcashprovidedbyusedininvestingactivities": 539000,
    "proceedsfromhedgefinancingactivities": 21150000,
    "proceedsfromconvertibledebt": 2197000,
    "paymentsofstockissuancecosts": 700000,
    "paymentsofdebtissuancecosts": 10000,
    "paymentsforrepurchaseofwarrants": 506000,
    "proceedsfromstockoptionsexercised": 58000,
    "netcashprovidedbyusedinfinancingactivities": 21120000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": 14862000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 16399000,
    "notesassumed1": 9365000,
    "stockissued1": 8883000,
    "debtissuancecostsincurredduringnoncashorpartialnoncashtransaction": 100000,
    "noncashorpartnoncashacquisitionvalueofassetsacquired1": 68000,
    "conversionofstockamountconverted1": 831000,
    "numberofsmallmoleculeproductcandidates": 2,
    "stockholdersequitynotestocksplitconversionratio1": 1.0565,
    "numberofoperatingsegments": 1,
    "cashuninsuredamount": 16100000,
    "financialliabilitiesfairvaluedisclosure": 27964000,
    "fairvaluemeasurementwithunobservableinputsreconciliationsrecurringbasisliabilityvalue": 27964000,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisvalueassignedtowarrantsuponinconnectionwithpremergerfinancing": 25821000,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilityissues": 768000,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilitysettlements": -506000,
    "fairvalueadjustmentofwarrants": 1945000,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisvalueassignedtotheunderlyingderivativesinconnectionwithconvertiblenotes": 831000,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisrevaluationduetoconvertiblenoteextinguishment": -3086000,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilitygainlossincludedinearnings": -459000,
    "propertyplantandequipmentusefullife": "P5Y",
    "contingentvaluerightspaymentperiod": "P15Y",
    "contingentvaluerightsipterm": "P10Y",
    "classofwarrantorrightoutstanding": 66538,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 0.0001,
    "weightedaverageremainingcontractualtermswarrants": "P2Y10M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 123,
    "lesseeoperatingleasetermofcontract": "P7M",
    "operatingleasesmonthlybaserent": 13000,
    "leaseandrentalexpense": 54000,
    "operatingleasesfutureminimumpaymentsnextrollingtwelvemonths": 78000,
    "prepaidexpensecurrent": 1243000,
    "otherassetscurrent": 26000,
    "propertyplantandequipmentgross": 20000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 11000,
    "accruedresearchanddevelopmentservicesandsuppliescurrent": 1440000,
    "employeerelatedliabilitiescurrent": 320000,
    "accruedprofessionalfeescurrent": 186000,
    "otheraccruedliabilitiescurrent": 25000,
    "notespayablefairvaluedisclosure": 1300000,
    "adjustmentstoadditionalpaidincapitalconvertibledebtwithoutconversionfeature": 1000000,
    "debtinstrumentunamortizeddiscountpremiumnet": 800000,
    "debtinstrumentinterestratestatedpercentage": 0.08,
    "interestexpenseshorttermborrowings": 500000,
    "proceedsfromissuanceofcommonstock": 5000000,
    "proceedsfromnewequityinvestments": 1000000,
    "debtinstrumentinterestrateinperiodofdefault": 0.12,
    "debtinstrumentunamortizeddiscountpremiumthirdparty": 8000,
    "notespayablerelatedpartiescurrentandnoncurrent": 700000,
    "numberofboardmembers": 4,
    "numberofofficers": 2,
    "numberofofficersalsoaboard": 1,
    "numberofdirectors": 5,
    "amountinvestedinpremergerfinancing": 300000,
    "numberofconvertedadditionalsharesreceivedbydirectors": 9444,
    "numberofdirectorssignedwaiveragreements": 6,
    "allocatedsharebasedcompensationexpense": 100000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P48M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 830167,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiod": 43002,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 895066,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 2.17,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 3.5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 1.23,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P1Y1M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": "P8Y1M20D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 7744000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 4712000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedintrinsicvalue": 6.49,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedweightedaveragegrantdatefairvalue": 2.77,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.868,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P7Y2M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.006,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 379576,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedoptionsforfeitednumberofshares": 43002,
    "commonstockcapitalsharesavailableforfutureissuance": 446843,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 2500000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P1Y6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 40000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 40000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 600,
    "paymentforlicenseagreement": 2100000,
    "futuremilestonemethodrevenuenotrecognized": 20000000,
    "numberoftradingdays": "P10D",
    "warrantsandrightsoutstandingterm": "P5Y",
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": 665836,
    "percentageofresetprice": 1.2,
    "derivativeassetmeasurementinput": 0.004,
    "fairvalueassumptionsexpectedlife": "P5Y",
    "fairvalueofwarrants": 25800000,
    "fairvalueofwarrantsexceeded": 21150000,
    "premergerfinancing": 4700000,
    "numberofinterestratederivativesheld": 1,
    "numberoftradingdaysincludingresetdate": "P45D",
    "periodofissuancedate": "P6M",
    "periodofafterissuancedate": "P1Y",
    "premoneyvaluationamount": 10000000,
    "noninterestexpensetransferagentandcustodianfees": 1600000,
    "legalfees": 200000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 123,
    "deferredtaxassetsoperatinglosscarryforwardsdomestic": 2700000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 300000,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 600000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.138,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.047,
    "effectiveincometaxratereconciliationnondeductibleexpenseacquisitionresearchanddevelopmentpercent": 0.088,
    "effectiveincometaxratereconciliationwarrantspercent": 0.076,
    "effectiveincometaxratereconciliationconvertiblenotespercent": -0.033,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": -0.001,
    "effectiveincometaxratereconciliationnondeductibleexpenseresearchanddevelopment": -0.011,
    "deferredtaxassetsoperatinglosscarryforwards": 3351000,
    "deferredtaxassetsgoodwillandintangibleassets": 547000,
    "deferredtaxassetstaxdeferredexpenseother": 8000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 466000,
    "deferredtaxassetsresearchanddevelopment": 275000,
    "deferredtaxassetsgross": 4647000,
    "deferredtaxassetsvaluationallowance": 4647000,
    "maximumperiodofsharesreservedunderplan": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardpercentageofoutstandingstockmaximum": 0.05
  }
]